Abstract

Here, we review quality of life and functional outcomes in bladder cancer patients after treatment and look for potential contributors. For the current scoring systems, we highlighted the specificity scales that are most commonly used in non-muscle invasive bladder cancer and muscle invasive bladder cancer. In addition, we go into the influence and bias of ileal conduit, robotic surgery, gender disparities, perioperative rehabilitation, bladder-preserving radiotherapy, pharmaceutical and immune chemotherapy, etc. on quality of life. Currently, although there are conflicts whether ileal conduit or orthotopic neobladder has a more positive impact on the prognosis of patients with bladder cancer, it is widely recognized that modern applications such as robotic surgery and pharmaceutical and immune chemotherapy improve the prognosis and quality of life of bladder cancer patients. Moreover, we discussed the differences in the adaptation of sex life quality between women and man after receiving various treatments. Surgical procedures that preserve organ integrity appear to improve patient’s quality of sexual life. Through this review, clinicians will have a better understanding of how important modern applications can grasp to improve the quality of life of their patients, with the goal of restoring their patient’s normal function and making it easier for them to re-join society.